LSNE Contract Manufacturing said that the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved the manufacturing of clinical stage biotechnology-based therapeutic products at its aseptic fill finish facility in León, Spain. This approval builds upon LSNE’s well-established capabilities in providing aseptic fill finish of biologic products for clients at its U.S. facilities. These products include monoclonal antibodies, fusion proteins, replacement enzymes, plasmids, capsids...